This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2029 Remove Pharma Companies Related Topics
Cell Based Assays Molecular Biology Clinical Development Biosimilars Vaccine RNA Clinical Research Pharmaceuticals Therapies Trials More Related Topics >
article thumbnail

What is the largest CRO in the US?

Vial

MARCH 1, 2024

billion by 2029. A 2022 survey by McKinsey found that emerging biotech companies are less satisfied with their CROs than large pharma companies and reported the feeling of being underserved. As a result, the global CRO market is estimated to grow at a compound annual growth rate (CAGR) of 9.6% from 2024 to reach US$129.8

Clinical Trials 52
Clinical Trials Clinical Research Laboratories Trials 52
article thumbnail

The trends driving ELRIG Drug Discovery 2022

Drug Discovery World

OCTOBER 4, 2022

This year has seen some major deals announced by big pharma companies. In May, Pfizer announced it would be acquiring the biopharmaceutical company Biohaven, which has a pipeline of therapies targeting migraines, for the sum of $11 billion. Collaborations have and will always be an important part of this industry.

Drugs 130
Drugs Therapies Clinical Trials Cell Based Assays 130
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024